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Abstract
The p12 protein is a cleavage product of the Gag precursor of the murine leukemia virus (MLV). Specific mutations in p12
have been described that affect early stages of infection, rendering the virus replication-defective. Such mutants showed
normal generation of genomic DNA but no formation of circular forms, which are markers of nuclear entry by the viral DNA.
This suggested that p12 may function in early stages of infection but the precise mechanism of p12 action is not known. To
address the function and follow the intracellular localization of the wt p12 protein, we generated tagged p12 proteins in the
context of a replication-competent virus, which allowed for the detection of p12 at early stages of infection by
immunofluorescence. p12 was found to be distributed to discrete puncta, indicative of macromolecular complexes. These
complexes were localized to the cytoplasm early after infection, and thereafter accumulated adjacent to mitotic
chromosomes. This chromosomal accumulation was impaired for p12 proteins with a mutation that rendered the virus
integration-defective. Immunofluorescence demonstrated that intracellular p12 complexes co-localized with capsid, a
known constituent of the MLV pre-integration complex (PIC), and immunofluorescence combined with fluorescent in situ
hybridization (FISH) revealed co-localization of the p12 proteins with the incoming reverse transcribed viral DNA.
Interactions of p12 with the capsid and with the viral DNA were also demonstrated by co-immunoprecipitation. These
results imply that p12 proteins are components of the MLV PIC. Furthermore, a large excess of wt PICs did not rescue the
defect in integration of PICs derived from mutant p12 particles, demonstrating that p12 exerts its function as part of this
complex. Altogether, these results imply that p12 proteins are constituent of the MLV PIC and function in directing the PIC
from the cytoplasm towards integration.
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Introduction
Reverse transcription and integration are the hallmarks of the
retroviral life cycle. These steps include reverse transcription of
the genomic RNA into a linear double-stranded DNA and the
subsequent integration of this DNA into the genome of the
infected cell. These events are part of the ‘early’ stages of the
retroviral life cycle, starting with the binding of the virus to its
cellular receptor and ending once the integration step has
occurred. Reverse transcription and integration are mediated by
the viral enzymes; reverse transcriptase (RT) and integrase (IN),
respectively; both are cleavage products of the polyprotein
encoded by the viral pol gene. Reverse transcription occurs in a
cytoplasmic complex, termed reverse transcription complex
(RTC), which transforms to the PIC (reviewed in [1,2]). The
PIC harbors the viral DNA and travels from the cytoplasm to the
nucleus, to target the chromatin of the infected cell for
integration.
The full composition of the RTC and PIC is not known; this is
true not only for the cellular components, but also for the viral
constituents of these complexes [2,3]. Some of the known cellular
components identified in RTC/PIC of different retroviruses
include: the barrier of auto-integration factor (BAF) [4,5], high-
mobility group proteins (HMGs) [6,7], Ku [8], lamina-associated
polypeptide 2a (LAP2a) [9], and lens epithelium-derived growth
factor (LEDGF/p75) [10,11]. To date, the viral protein compo-
nents identified in the RTC/PIC of the simple MLV include: RT
[12], nucleocapsid (NC) [13], capsid (CA) [12] and IN
[7,12,13,14]; while in the complex human immunodeficiency
virus type-1 (HIV-1), NC [15], matrix (MA) [16,17,18,19], RT
[15,16,17,18,19], IN [6,15,16,19,20] and Vpr [15,19] are present.
The trafficking of the PIC towards the chromatin of infected
cells might be substantially variable between different retroviruses.
This is demonstrated in part, by the fact that the nuclear entry by
the MLV PIC is strictly dependent on mitosis [21], whereas
nuclear entry by HIV-1 PIC can occur efficiently in nondividing
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contribute to such a variance; it has been shown that the MLV
PIC contains the viral CA protein [14], while the HIV PIC does
not [18]; this may contribute to the inability of wt MLV PICs to
enter the nucleus through the nuclear pores [27], and render the
MLV PICs dependent on nuclear envelope breakdown during
mitosis for nuclear entry [21].
One viral protein thought to influence the trafficking of the
MLV PIC, is the p12 protein. This protein is a cleavage product of
the Gag precursor, which is the major structural protein in the
virion. A few thousand Gag molecules assemble to form one viral
particle, and these are cleaved by the viral protease during the
virion maturation step. For MLV, this cleavage results in the
release of the following viral proteins: MA, p12, CA and NC. The
p12 domain is known to act in the late budding process of the Gag
precursor, and accordingly mutations in the p12 hamper virion
release [28,29,30,31]. However, additional mutations in this
protein have specifically affected early stages of MLV infections,
revealing a critical role for p12 in these stages [3,28,31,32,33].
Analysis of a subset of these mutants revealed normal generation of
the linear genomic DNA but no generation of circular viral DNA
forms. Such circular forms are thought to be formed by nuclear
enzymes from a portion of the linear viral DNA and although
these circles are not substrates for the IN [34,35,36], they serve as
a marker for nuclear entry by the viral DNA. Their absence
during the infection of the p12 mutants suggested that p12 may
function in directing the PIC into the nucleus or alternatively
affects unknown nuclear steps needed for integration. Importantly,
for at least one of these p12 mutants, the PIC appeared competent
for integration in an in vitro assay [3]. A later study provided
genetic evidence that p12 may function in concert with CA in
early stages of infection: using swap mutants between the different
domains of the Gag of MLV and its closely related virus, the
spleen necrosis virus (SNV), it was demonstrated that productive
infection can be achieved only when the p12 (or p18 from SNV)
and CA domains are from the same virus [37]. Although these
studies strongly indicate p12 participation in the early events of
MLV infection, the precise mechanisms of p12 action is not
known. Here we provide evidence that p12 is a part of the PIC
and functions from within this complex in early stages of infection.
Results
Generation of replication-competent MLV with tagged
p12 proteins
To study p12 function during the early stages of MLV life cycle,
we constructed epitope-tagged p12 to enable its visualization in
infected cells. Former mutagenesis studies have demonstrated that
MLV tolerates mutations in the central region of p12 rather than
in other parts of this protein [28,31,33,38] (Fig. 1). In addition, our
phylogenetic analysis revealed that the central region of p12 is
relatively less conserved between members of the MLV family,
further suggesting that this region may tolerate changes in its
sequence (Fig. 1). We then inserted into this region a triple repeat
of the Myc epitope (3xMyc; Fig. 1) to enhance detection of tagged
p12. The p12 protein of this virus could easily be detected by
Western blot analysis (Fig. 2A), but the replication of this mutant
was greatly reduced in comparison to wt (Fig. 2B). However, we
were able to recover a revertant virus with normal replication
kinetics, after repeated passages of the 3xMyc virus on naı ¨ve
NIH3T3 cells. A BsrGI-XhoI fragment of the revertant,
containing the entire p12 domain and flanking Gag sequences,
was PCR amplified and sequenced, revealing the existence of only
one in-frame copy of the Myc epitope in p12 with no other
mutations. This fragment was used to replace the wt sequence
between the BsrGI-XhoI restriction sites in a molecular clone of
MLV (pNCS, Materials and Methods), and the resulting virus was
named 1xMycR (Fig. 1). Further analysis of purified virions of the
1xMycR virus demonstrated that its p12 could be detected with
anti-Myc antibodies by Western blot analysis and, as expected, the
protein had a reduced molecular weight compared to p12 of the
3xMyc virus (Fig. 2A). Importantly, unlike the 3xMyc virus, the
1xMycR virus replicated with wt-like kinetics in NIH3T3 cells
(Fig. 2B), demonstrating that the reduction in the number of
repeats of the epitope tag in p12, accounted for the improved
replication of the latter virus.
Detection of the 1xMycR p12 in early stages of MLV
infection using immunofluorescence
Next, we examined whether p12 proteins can be detected by
immunofluorescence in 1xMycR-infected cells, using anti-Myc
antibodies. To unambiguously distinguish signals resulting from
authentic infection and background signals, we preformed the
infections with human cells (osteosarcoma; U2OS) that cannot be
normally infected due to the lack of the MLV receptor; or with a
cognate, U2OS-derived, cell line (U/R) that stably expresses the
mCAT-1 murine receptor for MLV [39], and is susceptible to
MLV infection (Materials and Methods). Parental U2OS or U/R
cells were infected either with 1xMycR or wt viruses, fixed and
immunostained with anti-Myc antibody. Clear punctate fluores-
cence could be detected in the cytoplasm of 1xMycR infected U/
R cells (Fig. 3A). We also observed a punctate staining of p12 that
was in close proximity to the chromosomes, in dividing cells that
were identified by their condensed chromosomes (Fig. 3B and see
below). In the control U/R cells, p12 staining was not observed
following infection with the wt virus (Fig. 3C); and very low p12
staining was observed in 1xMycR-infected parental U2OS cells
(Fig. 3D), likely representing a low level of adherence of the virus
to the cells. In addition, no immunofluorescence was observed in
mock-infected U/R cells or in 1xMycR-infected U/R cells that
were stained with the secondary, but not with the primary anti-
Myc antibody (data not shown). Thus, the majority of the punctate
staining represents a signal that is derived from an authentic
infection, and not from background staining or non-specific
adherence of viral particles or antibodies to the cell membrane.
Author Summary
All retroviruses reverse transcribe their RNA genome to a
DNA copy in the cytoplasm of the infected cell. To be
expressed, the viral genomic DNA has to travel to the cell
nucleus and to integrate into the cellular chromosomes.
This trafficking is governed by cellular and viral proteins
that associate with the viral genome to form a ‘pre-
integration complex’ (PIC), yet the full composition of this
complex is unknown. Former studies showed that for the
murine leukemia virus (MLV), mutations in a viral protein
named p12 abrogate MLV infection, after reverse tran-
scription and prior to the integration step, suggesting a
role for this protein in early stages of infection. However,
the precise mechanism of p12 action is not known. We
combined microscopic, genetic and biochemical tech-
niques to provide evidence that the p12 protein is part of
the MLV PIC and that it exerts its function from within this
complex. These analyses also suggest a role for p12 in the
trafficking of the PIC from the cytoplasm to the chromo-
somes of the infected cell. Altogether, these findings
highlight an important ‘building block’ of a complex that is
essential for MLV infection.
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was found between the number of p12 puncta in infected cells and
the amount of 1xMycR virions that were used for infection (Fig.
S1), suggesting that these dots represent p12 proteins that
originated from physical particles. The punctate pattern of staining
as opposed to a diffuse staining, suggests that the p12 molecules
are associated in a complex. Similar punctate staining was
observed when cells derived from the natural host of MLV
(murine NIH3T3 cells) were infected with the 1xMycR virus
(Fig. 3E). Of note, whereas clear immunofluorescence signal was
detected in 1xMycR-infected cells, no such signal was observed in
cells that were infected with the previously described replication-
competent MLV that contained a Flag-tagged p12 [33], and that
were stained with anti-Flag antibodies (data not shown). This
discrepancy may result from the different locations of the tags in
p12 and from the fact that the Flag epitope replaced few residues
in p12, while the Myc epitope was inserted into the complete
sequence of this protein, rendering this tag in the in 1xMycR virus
more accessible to the antibodies.
Detection of p12 in early stages of infection in dividing
and cell-cycle arrested cells
The early detection of p12 at 12 h postinfection (Fig. 3),
suggested that the immunofluorescence detected the p12 proteins
of the incoming virus and not the p12 domain of Gag precursors
Figure 1. Schematic representation of MLV genome, p12 sequence and mutations. Schematic representation of MLV genome with an
expanded view of the gag gene, demonstrating the MA, p12, CA and NC domains. The p12 protein sequence is aligned with the alanine blocks in
PM5 and PM14 viruses, which replace the wt residues (in bold) in these mutants [31]. Insertion sites in p12 of the Myc epitope sequences are marked
with an arrowhead. The black dots are aligned with a region that was found to tolerate mutations in previous studies [28,31], and residues in this
region that were found to be relatively variable by phylogenetic analysis (Materials and Methods) are marked with asterisks.
doi:10.1371/journal.ppat.1001183.g001
Figure 2. Characterization of virion production and replication of viruses with Myc-tagged p12 proteins. (A) Western blot analysis of
Myc-tagged p12 proteins. Equal amounts of plasmids, coding for 3xMyc and 1xMycR viruses were transfected into 293T cells. Mock are cells
transfected with no DNA. Virions were purified from culture supernatants two days posttransfection by ultracentrifugation through 25% sucrose
cushions. Tagged-p12 proteins in virion pellets were analyzed by Western blot using anti-Myc monoclonal antibody (9E10). The migration of the
cleaved Myc-tagged p12 protein is shown, highlighting the difference in size between the triple and single Myc-tagged p12. (B) Replication kinetics of
wt and 1xMycR viruses. Naı ¨ve NIH3T3 cells were infected with equivalent amounts of wt or 1xMycR virions (normalized by RT activity) and replication
kinetics were determined by radioactive exogenous RT assay. Culture supernatants were harvested at the indicated days postinfection and the arrows
indicate the days at which the infected cultures were diluted. Virion level in the sample is directly correlated to the intensity of the radioactive signal
[57]. Mock indicates infection with culture medium with no virus.
doi:10.1371/journal.ppat.1001183.g002
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examine this issue, we arrested the cell cycle of U/R cells by serum
starvation and aphidicolin treatment, as this procedure was shown
to block nuclear entry and integration of the incoming MLV,
averting Gag synthesis in later stages of infection [21]. We then
infected the cells with 1xMycR virus and observed the same
punctate fluorescent signal for p12 in the aphidicolin-treated cells
(Fig. 3F), confirming that p12 staining is of the incoming virus and
not of newly synthesized Gag precursors.
The p12 staining in aphidicolin-treated cells (Fig. 3F) was
mainly restricted to the cytoplasm, as was observed for cells that
were not treated with aphidicolin and that were in the interphase
stage of the cell cycle (Fig. 3A). In contrast, p12 was detected in
both the cytoplasm and in the vicinity of chromosomes of dividing
Figure 3. Immunofluorescence analysis of 1xMycR or wt -infected cells. Representative images of U/R (A, B, C and F), U2OS (D), or NIH3T3 (E)
cells that were infected with 1xMycR (A, B, D, E and F) or wt (C) viruses. 12 h postinfection the cells were stained with DAPI, anti-Myc monoclonal
antibody and a secondary, Cy-3-conjugated, anti-mouse antibody. Serum starvation and aphidicolin treatment were applied to arrest the cell cycle
prior and during the infection (F). Cultures were visualized with LSM 510 META confocal microscope (Zeiss) (A, B, C, D and F), or with spinning disk
confocal (Yokogawa CSU-22 Confocal Head) microscope (Axiovert 200 M, Carl Zeiss MicroImaging) (E). Bars represent 10 mm.
doi:10.1371/journal.ppat.1001183.g003
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cycling non-synchronized U/R cells were infected with 1xMycR
virus and 12 h postinfection the cells were fixed and stained for
p12 and the cellular DNA as described above. Mitotic cells were
identified on the basis of chromosome condensation and the
typical configuration of each mitotic stage. In addition, the extent
of p12 staining (red) that overlapped the staining of cellular DNA
(blue) was determined (see Materials and Methods), to quantify the
distribution of p12 proteins between the cytoplasm and the
chromosomes. Fig. 4 shows images of 1xMycR-infected cells at
different stages of the cell cycle, and the quantification of p12
distribution is represented in Fig. S2. As can be seen, p12 was
mainly detected in the cytoplasm of interphasic cells (Fig. 4A) with
only 6% overlap between p12 and the chromosomes (Fig. S2),
similar to what was shown above (Fig. 3A and F). In contrast, cells
at different stages of mitosis showed a much higher overlap
Figure 4. Immunofluorescence analysis of p12 proteins at different stages of the cell cycle. Dividing, non-synchronized U/R cells were
infected with 1xMycR (A–E and G–H) or with wt (F) viruses. 12 h postinfection the cells were stained as described in Fig. 3 and visualized with
spinning disk confocal (Yokogawa CSU-22 Confocal Head) microscope (Axiovert 200 M, Carl Zeiss MicroImaging). Stages of the cell cycle were
determined according to the condensation and separation of the chromosomes. A and F, interphase; B–E, prometaphase, metaphase, early and late
anaphase, respectively. G and H; single and serial optical sections of the chromosomes that appear in the inset in E, respectively. The serial sections
were reconstituted into a 3D image. Bars represent 10 mm.
doi:10.1371/journal.ppat.1001183.g004
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percentages of this overlap were quantified to be 49, 75, 68 and
72% at prometaphase, metaphase, as well as early and late
anaphase, respectively (Fig. S2). No p12 signal was detected in U/
R cells that were infected with wt virus and used to control for the
immunofluorescence specificity (Fig. 4F). Overall, complexes of
p12 proteins appeared to migrate from the cytoplasm to the
nucleus and to accumulate at the vicinity of the chromosomes in
dividing cells.
To further study the association of p12 with the chromosomes,
optical sections were generated for the mitotic chromosomes in
infected cells (inset, Fig. 4E). This microscopy analysis clearly
demonstrated that p12 proteins were detected at the same plane of
the chromosomes (Fig. 4G). Reconstitution of the serial optical
sections into a 3D image further showed the close proximity
between p12 proteins and the chromosomes (Fig. 4H). Thus, p12
proteins appear to be closely associated with, and even imbedded
in, the mitotic chromosomes of infected cells.
p12 co-localize with CA, but not with MA, in infected
cells
The above results implied that p12 proteins are found in
complexes that migrate from the cytoplasm to the chromosomes in
dividing cells. These resemble the characteristics of the PIC [21],
suggesting that p12 may be a constituent of this complex. If this
notion is true then in infected cells p12 should co-localize with
components of the PIC but not with virion constituents that are
not part of the PIC. To test this, we performed immunofluores-
cence analysis to detect the spatial relationships between p12 and
MA - a virion constituent that is thought to become dispersed in
the infected cell upon the uncoating step and is not known to be
part of the MLV PIC; and CA - a virion constituent that is part of
the MLV PIC [12]. 1xMycR-infected U/R cells were stained with
anti-Myc antibodies, together with anti- MA or CA antibodies.
This analysis revealed that, as expected for virion constituents, the
p12 (red fluorescence) and MA (green fluorescence) proteins co-
localized (yellow fluorescence) in particles that adhered to the
cover glass in regions that were free of cells (Fig. 5A, B). In
contrast, no such overlap could be detected between the p12 and
MA in the infected cells. The lack of co-localization between p12
and MA in the infected cells was further emphasized in conditions
where p12 proteins migrated towards the mitotic chromosomes
(Fig. 5B). When the distribution of CA and p12 was tested, co-
localization of the two proteins was clearly detected both in virions
that adhered to the glass outside the cell and in the infected cell
(Fig. 5C). Altogether, these immunofluorescence analyses demon-
strated that in the virions p12 proteins are co-localized with MA
and CA, yet in the infected cells p12 is associated with the CA but
not with the MA proteins, suggesting that p12 puncta in infected
cells are derived from uncoated virions and not from internalized
virus particles, and further hinting for p12 association with the
PIC.
p12 and the viral DNA co-localize in infected cells
To further address the possibility that p12 molecules are indeed
part of the MLV PIC we set to visualize the PICs in infected cells
and to test the possible co-localization of p12 with these PICs.
Since the presence of the viral DNA genome is the hallmark of the
PIC, its detection by FISH has been used to identify MLV PICs by
microscopy [21]. Thus, we aimed to detect the incoming PICs in
early stages of infection, using DNA FISH in combination with
immunofluorescence to define the time-dependent spatial corre-
lation between the viral genomic DNA and the p12 protein.
For this analysis we used U/R cells, to avoid the problem of
cross-hybridization with endogenous MLV-like elements found in
mouse cells [40]. In addition, to avoid detection of carry-over of
MLV plasmid DNA from transfected cells, we used viruses from
chronically infected NIH3T3 cells. In preliminary FISH experi-
ments we could readily detect clear and punctate fluorescence
staining in U/R, but not in U2OS, cells that were infected with wt
virus and that were hybridized with a MLV-derived, biotin-labeled
probe that was detected with a Cy3-conjugated avidin, demon-
strating the specificity of the detection method (Fig. S3 and see
below). This staining was also reminiscent of the previously
reported staining of MLV PICs by FISH in Rat-1 cells [21]. We
then established conditions for immunofluorescence combined
with DNA FISH (see Materials and Methods). U/R or U2OS cells
were infected with 1xMycR or wt viruses, and 12 h postinfection,
cells were stained with anti-Myc antibody and a secondary Cy3-
conjugated antibody. FISH analysis followed, using a MLV-
derived biotinylated probe and FITC-labeled avidin for the
detection of the probe. A clear overlap (yellow) between the p12
proteins (red) and the MLV genomic DNA (green) was observed in
U/R cells infected with 1xMycR virus (Fig. 6A–E). This overlap
could be observed in the cytoplasm of infected cells (Fig. 6A, B, D
and E), as well as in the vicinity of chromosomes (Fig. 6C),
including condensed chromosomes of mitotic cells (Fig. 6B, E and
S4). In contrast, such broad overlapping signals were absent in
1xMycR-infected U/R cells that were processed for immunoflu-
orescence/FISH analysis at two hours postinfection (Fig. 6F). In
this setting, only extensive punctate staining of p12 was observed,
probably reflecting the lack of complete reverse transcription at
this early time point. Quantification of more than 600 fluorescent
dots in infected cells (Fig. S5) confirmed the above observations: at
12 h postinfection approximately 60% of the fluorescent puncta
showed an overlapping signal between the p12 proteins and the
viral genomic DNA, while approximately only 10 and 30 percents
of the fluorescent dots showed such an overlap at earlier time
points (2 and 6 h postinfection, respectively). In addition, at 12 h
post infection about 10% of the total fluorescent dots, showed
overlapping p12 and genomic DNA signals that could be located
with the chromosomes. In contrast to these results, more than 99%
of the extracellular dots (representing extracellular virions attached
to the glass in cell-free regions, see Fig. 5), showed only p12
staining both at early (2 h) and late (12 h) time point postinfection
(Fig. S5), likely due to the absence of efficient reverse transcription
in these particles. Additional negative controls showed no
overlapping signals between the p12 and the genomic DNA
staining further emphasizing the genuineness of this analysis.
These controls included: 1xMycR-infected U/R cells that were
processed as above but without the addition of the primary anti-
Myc antibody, showing only the green FISH signal (Fig. 6G); U/R
cells, infected with the wt virus that lacks the Myc epitope, showing
only the green FISH signal (Fig. 6H) and 1xMycR-infected U2OS
cells, showing neither red nor green punctate fluorescence (Fig. 6I).
Thus, the overlapping staining in 1xMycR-infected U/R cells,
which was absent from the extracellular particles and from the
negative controls, suggested that p12 proteins associate with viral
genomic DNA and hence, p12 is indeed a component of the MLV
PIC. Moreover, the overlap between p12 protein and viral DNA
that was detected in close proximity to the condensed chromo-
somes (Fig. 6B, E and S5) suggested that p12 proteins escort the
viral DNA until very close to the chromatin of dividing cells.
As was suggested above, the absence of intracellular overlapping
immunofluorescence/FISH signals at two hours postinfection
(Fig. 6F) likely reflected the lack of complete reverse transcription
at this early time point, and may further suggest that reverse-
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infected cells. We further investigated this point by the generation of
MLV virus-like particles (VLPs), with or without the genomic RNA,
and that their p12 proteins were Myc-tagged as the 1xMycR virus
(Materials and Methods). These VLPswere then used to infect U/R
cells, which were examined by immunofluorescence for the
generation of p12 puncta. Thisanalysis revealed a similar formation
of p12 puncta, and similar accumulation of these dots close to
mitotic chromosomes, for both conditions (Fig. S6). These results
suggest that the presence of the genomic RNA, and its subsequent
reverse transcription, are not a prerequisite for the formation and
migration of p12 puncta in infected cells.
Figure 5. Analysis of the co-localization of p12 with MA or CA. U/R cells were infected with the 1xMycR virus and analyzed by
immunofluorescence, as described in Fig. 3. p12 (A–C), MA(A, B) and CA (C) were detected with the anti-Myc monoclonal antibody, goat anti-MA and
goat anti-CA polyclonal antibodies, respectively, and the matched secondary FITC-conjugated donkey anti-mouse IgG and Red-X- conjugated donkey
anti-goat IgG. For consistency, the images were pseudocolored to present p12 in red and MA or CA in green. Dashed lines mark the boundaries of
cell-free regions where virions were detected attached to the cover glass. Bars represent 10 mm.
doi:10.1371/journal.ppat.1001183.g005
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It should be noted that in 1xMycR-infected U/R cells, we also
observed signals for the viral DNA and the p12 proteins that did
not overlap (Fig. 6D and E; triangles and ellipses, and Fig. S5).
Since only a fraction of the incoming viruses establish a productive
infection [2,41,42], our microscopic analysis cannot resolve
between the following two options: 1) only PICs that include
functional p12 proteins have the potential to complete the early
steps of infection or; 2) PICs that do not contain p12 are the
infectious ones. Since p12 is crucial for MLV infection [3,31,33],
in the latter scenario, p12 proteins function not as part of the PIC
but autonomously, outside of this complex.
To address the question whether p12 modifies PIC function as
part of the PIC or by acting separately from the PIC, we designed
Figure 6. Detection of viral p12 proteins and genomic DNA by immunofluorescence combined with FISH. U/R cells (A–H) or U20S (I)
were infected with 1xMycR (A–G, I) or wt (H) viruses, and 12 h (A–E, G–I) or 2 h (F) postinfection the cells were processed for immunofluorescence and
FISH analysis. Myc-labeled p12 proteins were detected with a primary anti-Myc monoclonal antibody (A–F, H–I) and a secondary Cy-3-conjugated
anti-mouse antibody (A–I). The immunodetection in G was performed with only the secondary, but not the primary, antibodies. The genomic DNA
was detected with MLV-derived biotin-labeled probes and a FITC-conjugated avidin (A–I). D and E are magnifications of the insets in A and B,
respectively. Arrows indicate overlaps between the viral p12 proteins and the genomic DNA signals. Ellipses and triangles show non-overlapping
signals of the p12 and the genomic DNA, respectively. Images A, B, D, E and G–I were taken with a BX50 microscope (Olympus) or with a LSM 510
META confocal microscope (Zeiss) (C and F). Bars represent 10 mm.
doi:10.1371/journal.ppat.1001183.g006
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wt and mutant p12 proteins. If p12 functions as a constituent of
the PIC, upon co-infection of wt and p12 mutant viruses the wt
p12 proteins should not rescue the defect in integration of PICs
derived from the p12 mutant virus (Fig. 7A). In contrast, rescue
should occur if p12 proteins act autonomously of the PIC,
particularly in conditions where wt p12 proteins are present in
large excess over mutant p12 proteins (Fig. 7B). Two types of
MLV particles were generated for this assay: The first, named
MLVIRES-GFP, was expressed from the pNCAIRES-GFP clone, a
replication-competent MLV with a GFP marker [43], allowing the
accurate determination of its titer. MLVIRES-GFP expresses wt p12
proteins. The second type was made of VLPs that were generated
from helper plasmids expressing the MLV Gag with or without the
PM14 mutation in p12 (Fig. 1), and the Pol and Env (ecotropic)
proteins; these VLPs also encapsidated the pQCXIN retroviral
vector (Clontech), expressing the neomycin resistance gene (Neo
r).
Importantly, pQCXIN is a self-inactivating vector due to a
deletion in the U3 sequence of the 39 LTR, which renders the
vector compatible for only a single cycle of infection even in the
presence of replicating virus such as the MLVIRES-GFP. We chose
the PM14 mutation for this analysis since a virus that carries this
mutation is capable of normal reverse transcription but is defective
in integration [31]; yet, in our hands, VLPs with the PM14
mutation could transduce the pQCXIN vector at low but
detectable efficiencies, allowing the quantification of p12 function
in this complementation assay.
NIH3T3 cells were infected with dilutions of wt VLPs (MOI of
0.2, 0.1 or 0.01), or PM14 VLPs (with RT activities that matched
the ones of the wt VLPs dilutions), in the presence or absence of
MLVIRES-GFP (MOI of 10). In these settings, the wt p12 proteins,
derived from MLVIRES-GFP, are present in large excess over
decreasing amounts of VLP-derived p12 proteins (wt or mutant) in
infected cells. Infected cultures were then selected in G418-
containing medium for two weeks, after which the number of Neo
r
colonies was determined (Fig. 7C). The results of this experiment
showed that in all tested ratios, no increase in the number of Neo
r
colonies was observed for the PM14 VLPs (Fig. 7C, white columns)
in the presence of MLVIRES-GFP, indicating that p12 proteins act
from within the PIC. In fact, co-infection of MLVIRES-GFP with
either wt (Fig. 7C, black columns) or mutant VLPs resulted in a
reduction in the number of Neo
r colonies; the level of this decrease
augmented with the increase of MLVIRES-GFP/VLP ratio. This
phenomenon likely represents competition between MLVIRES-GFP
andthe VLPs overcellularfactor(s) neededtoestablishtheinfection.
Of note, the reduction in the number of Neo
r colonies in the
presence of MLVIRES-GFP was greater for the PM14 VLPs,
compared to the wt VLPs, at all the tested ratios. For example,
when the presence of MLVIRES-GFP reduced the infectivity of wt
VLPs by less than two-fold, a reduction of more than eight-fold was
observed for PM14 VLPs. These results suggest that the PM14
mutant is more sensitive to the competition exerted by the
MLVIRES-GFP virus.
Similar results were obtained when we repeated this experiment
using VLPs (wt and PM14) that were pseudotyped with the
vesicular stomatitis virus G glycoprotein (VSV-G) instead of the
ecotropic MLV envelope protein, to avoid direct competition
between the VLPs and the MLVIRES-GFP virus on the mCAT-
1receptor, (Fig. 7D). No rescue of the infectivity of the p12
mutants was observed when these experiments were repeated
using different conditions that included lower MOIs, the use of wt
VLPs (instead of the replicating MLVIRES-GFP virus) as a source
for the wt p12 proteins, and PM14 VLPs encapsidating a vector
with a different selection marker (data not shown). Overall, these
experiments provide genetic evidence that p12 functions as part of
the PIC.
Co-immunoprecipitation (Co-IP) of p12 proteins and the
viral genomic DNA and CA proteins
As mentioned above, the exact composition of retroviral PIC is
not known, however the presence of the viral genomic DNA is the
hallmark of the PIC. To further demonstrate that p12 is a
component of the PIC we aimed to co-immunoprecipitate the viral
genomic DNA with the p12 proteins. To immunoprecipitate p12,
we infected NIH3T3 cells with wt or 1xMycR virus, lysed the cells
and performed IP with anti-Myc, or control anti-Flag monoclonal
antibodies. We then analyzed the cell lysates and the immuno-
precipitates for the presence of the viral genomic DNA by PCR.
This analysis revealed preferential IP of the genome of the
1xMycR virus when anti-Myc antibodies were used, compared to
the controls (Fig. 8A). To better quantify this, we measured the
amount of the viral DNA genome in the cell lysates and the
immunopellets by quantitative PCR (qPCR) and calculated the
relative efficiency of this IP (Fig. 8B and S7A). The average IP
efficiency, obtained from three independent experiments, showed
that when anti-Myc antibodies were used, the genome of the
1xMycR virus was immunoprecipitated approximately 7 fold
higher than the genome of the wt virus. In addition, the average IP
efficiency of the 1xMycR genome by the anti-Myc antibodies was
approximately 25 fold higher than the one obtained for IP using
anti-Flag antibodies. This specific IP of the viral genomic DNA
with antibodies against p12 strongly suggested that p12 is indeed
part of the PIC.
Since CA was identified as a component of the MLV PIC [14]
we also tested if this protein co-immunoprecipitates with the p12
proteins. Co-IP experiments were performed similarly to what was
described above for the IP of the viral genomic DNA. The
presence of CA in cell lysates and in immunopellets was
determined by Western blot analysis with polyclonal antibodies
against CA (Fig. 8C). This analysis revealed that CA could be
detected in the precipitate only when the precipitation included
the lysates of the 1xMycR-infected cells and the anti-Myc
antibodies; CA protein was absent from control precipitates
obtained from wt-infected cell lysates that were reacted with anti-
Myc antibodies, or from lysates of 1xMycR-infected cells that were
reacted with the control anti-Flag antibodies.
To verify that the detected p12-CA interaction reflects an
authentic, intracellular interaction and not an interaction present
in internalized virus particles, we carried out an analogous pull-
down experiment on both extracellular virions and infected cells.
The results of this experiment clearly demonstrate that CA of the
1xMycR virus was immunoprecipitated by anti-Myc antibodies
only from lysates of infected cells and not from lysates of
extracellular virions (Fig. S7B and C). These results indicate co-
association of CA - a known component of the MLV PIC - and
p12 proteins, further providing evidence that p12 is indeed a
component of the PIC.
Mutant p12 proteins fail to traffic towards mitotic
chromosomes
Our data provide strong evidence that p12 is a functional
component of the PIC. Yet, the exact function of p12 is currently
unknown. In principle, p12 may influence one or more steps that
include: migration of the PIC along the cytoplasm, nuclear entry
and targeting the chromatin for integration. Elaborate biochem-
ical analysis of cells infected with wt MLV or with an integration-
defective p12 mutant - the PM14 virus - demonstrated that the two
p12 Is a Functional Constituent of the MLV PIC
PLoS Pathogens | www.plospathogens.org 9 November 2010 | Volume 6 | Issue 11 | e1001183Figure 7. A complementation assay between wt and mutant p12 proteins. Schematic representation of the expected outcome of co-
infection experiments with wt and p12 mutant viruses if p12 functions as a constituent of the PIC (A), or autonomously of the PIC (B). Gray hexagons
represent PICs and black or empty circles represent wt or mutant p12 proteins, respectively. Arrowhead or T-shaped arrow represents productive or
abortive integration, respectively. The total number of Neo
r colonies (colony forming units; CFU) obtained from NIH3T3 cells that were infected with
the wt (black bars) or the PM14 mutant (white bars) VLPs carrying the Neo
r vector, and pseudotyped with the ecotropic MLV envelope (C) or the VSV-
G glycoprotein (D) are shown. The combination of the MOIs of the MLVIRES-GFP virus and the VLPs are indicated below the bars. The numbers over the
broken arrows indicate the fold reduction in the CFU of the VLPs due to the co-infection with the MLVIRES-GFP virus.
doi:10.1371/journal.ppat.1001183.g007
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cytoplasmic and nuclear fractions; yet no circular genomic DNA
was detected for the mutant virus, suggesting that PM14 virus is
defective in nuclear steps required for productive infection [3].
However, as the authors suggested, association of the PIC of the
PM14 virus to the external side of the nuclear envelope and/or
nuclear retention could not be dismissed. We tested if the
immunofluorescence procedure that we developed to investigate
1xMycR infection could be applied to the analysis of mutant p12
proteins. For this we introduced the PM14 mutation (Fig. 1) into
p12 of the 1xMycR clone to generate the 1xMycR/PM14 virus.
We then separately transfected the 1xMycR and the 1xMycR/
PM14 clones into 293T cells, harvested the virion-containing
supernatants and infected sub-confluent U/R cultures with equal
amounts of virions (normalized by an exogenous RT assay). The
infected cells were processed for immunofluorescence analysis
12 h postinfection with anti-Myc antibodies to detect the p12
proteins. This analysis revealed that both viruses showed similar
intracellular distribution in interphasic cells, where the majority of
the p12 proteins were cytoplasmic (Fig. 9). However, a remarkable
difference between the wt and the mutant virus was observed in
mitotic cells, where the p12 proteins of the 1xMycR/PM14 virus
Figure 8. Co-IP of p12 with the viral genomic DNA and CA proteins. Lysates were prepared from NIH3T3 cells, infected with wt or 1xMycR
viruses. To detect the viral genomic DNA (A and B) the lysates were incubated with anti-Myc (labeled ‘aMyc’), or control anti-Flag antibodies (labeled
‘aFlag’); both conjugated to protein G magnetic beads. Viral genomic DNA was PCR amplified from cell lysates (labeled ‘Input’) and from the
magnetic beads (labeled ‘IP’) with MLV specific primers. After 25 and 30 cycles of amplification, the PCR products (875 bp long) were electrophoresed
in 1% agarose gels containing ethidium bromide (A). ‘Mock’ indicates mock-infected NIH3T3 cells. Water and plasmid encoding the MLV genome
(‘pNCS’) were used as negative and positive PCR controls, respectively. (B) The ‘Relative IP efficiency’ of the viral genomic DNA was quantified by qPCR
(Materials and Methods) and is presented as the means 6 the standard error of the means, obtained from three independent experiments. The qPCR
values are presented in Fig. S7A. To test for CA immunoprecipitation (C), NIH3T3 were infected as in (A) and 15% of the indicated cell lysate was used
to determine total CA levels (labeled ‘Cell Lysates’). The remaining lysates (labeled as in A) were used for IP with anti-Myc, or control anti-Flag
monoclonal antibodies, bound to agarose beads. Cells exposed to medium with no virus served as a mock control. Pellets (labeled ‘IP’) and cell
lysates were analyzed by Western Blot, using anti-CA polyclonal antibodies.
doi:10.1371/journal.ppat.1001183.g008
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substantial association of the p12 proteins of the 1xMycR virus
with the chromosomes (Fig. 9). Further quantification of this
phenomenon revealed that in interpahsic cells about 8% of the
p12 proteins that were derived from the 1xMycR/PM14 virus
overlapped the chromosomes, similar to the value (6%) obtained
for the 1xMycR virus (Fig. S8). In mitotic cells, however, where
almost 70% of the p12 proteins of the 1xMycR virus overlapped
the chromosomes, the p12 proteins with the PM14 mutation
showed only 11% overlap - a level that was similar to the one
obtained in interphasic cells (Fig. S8). These results demonstrated
that the PM14 mutation hindered the movement of the p12
proteins from the cytoplasm towards the chromosomes and
strongly suggest a role for p12 in PIC trafficking.
Discussion
In this work we provide microscopic, genetic and biochemical
evidence that the p12 protein - a Gag cleavage product - is a
functional constituent of the MLV PIC.
We used fluorescent microscopy analysis to detect Myc-tagged
p12 proteins of a replication-competent virus (1xMycR), in
infected cells. The comparison between the epitope-tagged virus
and the untagged wt virus, and between infected cells that express,
or do not express, the mCAT-1 receptor for MLV, allowed us to
distinguish unambiguously between background signals and
immunofluorescent staining that was related to authentic infection
of the incoming virus. This is important since MLV particles with
the ecotropic envelope may bind human cells independently of
Figure 9. Immunofluorescence analysis of p12 proteins of the 1xMycR and the 1xMycR/PM14 viruses in infected cells. Dividing, non-
synchronized U/R cells were infected with 1xMycR (A–C) or with the 1xMycR/PM14 (D–E) viruses. 12 h postinfection the cells were stained and
visualized as described in Fig. 4. Interphasic (A and D) and mitotic (B, C, E and F) cells were identified according to the condensation of the
chromosomes. Bars represent 10 mm.
doi:10.1371/journal.ppat.1001183.g009
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detected by immunofluorescence [42].
When susceptible U/R and NIH3T3 cells were infected with
the 1xMycR virus, our immunofluorescence analysis revealed
punctate p12 staining at an early time of infection. This staining
was attributed to the incoming virus, and not to newly synthesized
Gag proteins since it could be detected as early as two hours
postinfection, and in aphidicolin-treated cells, where integration
and the subsequent Gag expression are inhibited. Of note,
throughout the immunofluorescence experiments, the cells were
infected with MOI of approximately 3, yet many of the infected
cells exhibited hundreds to thousands of p12-positive dots This
likely reflects the fact that for retroviruses only a minute fraction of
the virions is infectious [41,42]. The number of these dots was in a
direct correlation with the amount of the virus used for infection.
Thus, it is likely that the majority of these dots represent p12
proteins that originated from physical particles that are defective in
their infectivity.
The punctate, rather than diffuse, pattern of the staining of p12
suggested that p12 proteins are found in a complex in early stages
of the infection cycle. Furthermore, this staining was mainly
cytoplasmic in aphidicolin-treated cells or in mitotic cells early
after infection, in contrast to its localization adjacent to mitotic
chromosomes 12 h postinfection. Thus, the pattern and the
distribution of p12 proteins in dividing, and in cell-cycle arrested
cells, resemble the one of the MLV genomic DNA [21], suggesting
that p12 is part of the MLV PIC. In support of this idea are the
findings that whereas p12 staining overlapped the staining of MA
or CA in virions, in the infected cells p12 staining co-localized only
with that of CA, which unlike the MA protein is thought to be part
of the MLV PIC. However, in principle, p12 proteins can migrate
towards the cellular chromatin as PIC-independent complexes.
Therefore, to better evaluate p12-PIC interaction we combined
immunofluorescence with FISH analyses, and detected co-
localization of p12 proteins with the viral genomic DNA, both
in the cytoplasm and in close proximity to the cellular chromatin
of infected cells. Since the viral genomic DNA is the hallmark of
the PIC, this co-localization suggested that p12 is indeed part of
the PIC. The early detection of punctate p12 staining at two hours
postinfection, when almost no FISH signal for the genomic DNA
could be detected, hints for organization of p12 proteins in a
complex that precede the PIC, most likely in the RTC. Moreover,
the appearance of p12 puncta in cells that were infected by MLV
VLPs with no encapsidated genomic RNA suggests that the
presence of the genomic RNA is not necessary for the early
organization of p12 in complexes and their trafficking towards the
chromosomes. In this scenario, the protein components of the
RTC and the PIC may have intrinsic assembly ability which is
independent of the presence of the genomic RNA and/or cDNA.
Our analysis revealed, however, that not all the signals of the
p12 proteins and the viral DNA genome overlap, raising the
possibility that p12 proteins may function in early stages of
infection not as constituents of the PIC but as elements that are
separated from this complex; in any scenario, such variation in the
association of p12 with the viral genomic DNA may account in
part for the fact that only a fraction of MLV particles are
infectious. Since our microscopic examination could not unam-
biguously distinguish between these two scenarios describing p12-
PIC interactions, we performed a genetic ‘rescue’ assay to evaluate
if p12 proteins exert their activity in trans, in respect to the PIC, or
as constituents of this complex. In this assay, VLPs that were
defective in early steps of infection - between reverse transcription
and integration - due to a mutation in p12 (PM14 mutation; [31])
were used together with wt virus (pNCAIRES-GFP) to co-infect
NIH3T3 cells. The presence of wt p12 proteins in the infected cells
did not improve the infectivity of the mutant VLPs and this was
true for all wt-to-mutant ratios tested, including conditions where
wt p12 proteins were present in a very large excess over the
mutant p12 proteins. These results strongly suggest that p12
proteins function as part of the PIC. The co-infection experiments
also revealed that excess of pNCAIRES-GFP particles repressed the
infection of the VLPs regardless if the latter harbored wt or mutant
p12 proteins, and that the level of this inhibition rose with the
increase in the pNCAIRES-GFP-to-VLPs ratio. This probably
reflects a competition between the pNCAIRES-GFP virus and the
VLPs on cellular factor(s) needed to establish infection and that are
found in limiting amounts. The ecotropic receptor may serve as
such a factor since more Neo
r colonies were obtained when the
pNCAIRES-GFP virus and the VLPs (transducing the Neo
r vector)
had different (the ecotropic and the VSV-G glycoprotein, respec-
tively), instead of the same, envelopes, resulting inthe use of different
receptors to initiate infection. However, even in such settings, excess
of pNCAIRES-GFP over the VLPs resulted in a dose-dependent
reduction in the infectivity of the latter, suggesting that saturable
cellular factors other than the ecotropic receptor exist. Notably, the
PM14 VLPs were more sensitive to the pNCAIRES-GFP-mediated
suppression, compared to wt VLPs. This phenomenon may indicate
that PM14 VLPs are kinetically slower than wt VLPs in transducing
the vector. In this scenario, wt PICs may traffic towards integration
faster than the PICs with mutant p12 proteins and accordingly,
saturate cellular factors needed for infection, before such factors will
be available for the mutant PICs.
The above results suggest that p12 is a constituent of the PIC
and thus, it is anticipated that the viral genomic DNA should be
co-immunoprecipitated with p12 proteins. Indeed, preferential IP
of the genome of the 1xMycR virus with anti-Myc antibodies from
infected cells was identified, compared to the controls (made of the
wt virus or anti-Flag antibodies), providing strong evidence that
p12 proteins are found in a complex with the viral genomic DNA.
Further biochemical support to the interaction of p12 with the PIC
came from the detection of CA, another component of the MLV
PIC [14], in the p12 immunoprecipitates, as CA proteins were
immunoprecipitated from lysates of cells that were infected with
the 1xMycR virus, using anti-Myc antibodies. It should be noted
that we failed to directly detect the Myc-tagged p12 proteins in the
pellets where CA proteins were found. This may be the result of
the use of a monoclonal antibody (anti-Myc) to detect p12, unlike
CA detection that was performed using polyclonal sera that may
enhance the sensitivity of the detection. Support for this
explanation comes from the fact that Western blot analysis of
virions showed an intense signal for CA but a relatively weak signal
for p12, although the two proteins are present in equimolar
quantities inside the viral particles; the difference in detection
sensitivity by Western blot analysis was also observed when only
CA, but not p12, was detected in extracts of the 1xMycR-infected
cells prior to the IP step (data not shown). Importantly, although
this analysis was not sensitive enough to detect the tagged p12
proteins, CA IP was specific since it was observed only when the
1xMycR virus and the anti-Myc antibody were used, and not
when the co-IP was performed with controls that included an
isotype-matched control antibody (IgG1, anti-Flag) or the
untagged, wt virus. In the co-IP experiments, only low amounts
of CA were detected in the pellets, compared to its level in the cell
lysates. This may reflect a labile p12-CA interaction and/or the
possibility that not all of the CA molecules interact with p12
proteins. At this stage, it is not clear whether the p12 and CA
proteins are complexed together through direct or indirect
interactions; yet, our success to detect this interaction in infected
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p12 and CA molecules in the virion form new mutual interactions
during or after the uncoating step. In any case, these co-IP
experiments provide a biochemical support to the notion that p12
and CA proteins have a cooperative effect in early stages of
infection, as was concluded from the analysis of swap mutants
between the different domains of the Gag of MLV and its closely
related virus - the SNV [37]. Because CA is a component of the
MLV PIC and since our analysis suggests that p12 is also a
functional constituents of the same complex, the two proteins may
act in concert to direct the PIC towards nuclear entry and
integration. In line with this idea is the observation, made by Yuan
et al. [3], and Lee et al. [37], regarding the phenotypic similarity
that exists between wt MLVs that are restricted by the Fv1
restriction factor and mutant MLVs harboring either specific
mutations in p12, or p12/CA chimeras derived from MLV and
SNV. In each of these cases virus infection is characterized by
normal levels of reverse transcription but defective production of
genomic circular forms and integration.
If p12 proteins act in directing the PIC towards integration,
their function(s) may be required during PIC migration through
the cytoplasm, nuclear entry and/or nuclear trafficking. Remark-
ably, we demonstrated here a clear accumulation of the p12
proteins adjacent to mitotic chromosomes, and this accumulation
appeared to increase along the steps of mitosis; ranging from 6%
of p12 proteins that overlapped the chromatin during interphase,
to about 70% overlap during mitosis. Moreover, the PM14
mutation in p12 that renders the virus integration-defective in vivo
[3], also hindered the accumulation of p12 proteins with the
mitotic chromosomes, as the majority (,90%) of the puncta of the
p12 mutant proteins remained cytoplasmic in dividing cells. These
results are in agreement with the postulation, discussed above, that
wt PICs are kinetically faster in their trafficking towards
integration, than PICs that are derived from the infection of the
PM14 virus. Yet, it should be noted that Yuan et al. [3], observed
that the distribution of the viral genomic DNA between the
cytoplasm and the nuclear fractions was similar for both the wt
and the PM14 mutant viruses. While our microscopic analysis
revealed such similarity for the p12 content in the nucleus of
interphasic cells, our results also showed differential nuclear-
cytoplasmic distribution of p12 in mitotic cells, for the two viruses.
This difference can be explained by the different methodologies
used: whereas our microscopy analysis monitored the infection in
individual mitotic cells, in which the nuclear envelope is broken,
the biochemical fractionation used by Yuan et al., relayed on the
lysis of unsynchronized infected cultures and the subsequent
separation of intact nuclei from the cytoplasm. In such conditions,
mitotic cells with no intact nuclei can be overlooked, especially if
these cells present only a fraction of the unsynchronized culture.
Altogether, our results suggest that p12 proteins are associated
with the viral genomic DNA and indicate for a role(s) of p12 along
the course of trafficking of this DNA from the cytoplasm to the
chromosomes. One possibility of such a role is that p12 interacts
with cytoplasmic factors that are required for trafficking towards
the nucleus. Such specific factors have not been identified for
MLV, but may involve cytoskeleton proteins, as was described for
HIV and other retroviruses [3]. In addition, the extensive
accumulation of p12 in close proximity to the chromosomes hints
for a role of p12 very close to the integration step and may even
indicate for a direct function in the integration process itself.
However, Yuan et al. [3], have demonstrated that PICs derived
from a MLV with a mutation in p12 that render the virus
integration-defective in vivo, were integration-competent in an in
vitro assay; demonstrating that a defect in p12 function does not
necessarily hamper PIC-mediated integration. Thus, p12 may be
needed at the vicinity of the chromatin for steps that precede the
integration reaction itself. What could be such a role? For HIV-1,
it has been demonstrated that the cellular protein LEDGF is a
component of the PIC [10,11] and may serve to tether the IN
proteins to the chromatin [10,44,45,46,47]. LEDGF interacts with
IN proteins derived from several lentiviruses but not with MLV IN
[10,48], and no factor with such tethering activity has been
described for MLV. In light of the similarity of the N-termini of
p12 and the histone H5 protein [49], and because our microscopic
data showed an intimate association of p12 with the chromatin it is
tempting to assume that p12 also functions in tethering the MLV
PIC to the chromatin. Such a scenario may explain why specific
mutations in p12 block MLV integration in live cells but do not
interfere with integration into naked DNA, in vitro [3].
The ability to detect MLV PICs by immunofluorescence
through the detection of p12 proteins provides a new tool that
may assist the analysis of several issues concerning MLV infection:
(i) such microscopic analysis should complement the biochemical
approach used to study p12 mutants and resolve, for example, the
question whether PICs of specific p12 mutants are capable of
entering the nucleus or are trapped on the external side of the
nuclear envelope [3]; (ii) p12 tagging may also be applied for the
analysis of the recently discovered human retrovirus, the XMRV,
which expresses p12 protein with a high degree of similarity to the
MLV p12; suggesting a way to monitor XMRV infection in
human cells; (iii) Means were developed to visualize HIV-1 RTC/
PIC, which were also exploited to study the interaction of these
complexes with the TRIM5a restriction factor [50]. Similarly,
tagging p12 proteins of N or B -tropic MLVs with the Myc
epitope, as was described here for the 1xMycR virus, should allow
the analysis of the restriction of these MLVs by Fv1 [51], and
TRIM5a-mediated restriction of N-tropic MLV [52,53].
In summary, the combination of microscopic, genetic and
biochemical assays described here provide strong evidence that
p12 is a component of the MLV PIC and this interaction is crucial
for the progression of the PIC towards integration.
Materials and Methods
Viruses
The pNCS plasmid contains an infectious molecular clone of
the Moloney MLV [54], and a simian virus 40 origin of replication
in the plasmid backbone. Overlapping PCR was used to insert
three tandem repeats of the Myc epitope (EQKLISEEDL),
between amino acids 45 and 46 of p12 in pNCS, generating the
3xMyc clone. Virions of a faster replicating revertant, which was
derived from the 3xMyc virus, were collected and the genomic
RNA was extracted and reverse transcribed with MLV RT and
random primers (Promega). The cDNA was amplified by PCR
using Ex-Taq (Takara Bio Inc.) and a forward primer
(59CCCAGGTTAAGATCAAGG39, derived from the matrix
sequence), together with a reverse primer (59CTTGGCCA-
AATTGGTGGG39, derived from the capsid sequence). The
resulting 875 bp fragment was cloned into pTZ57R (Fermentas)
and sequenced, revealing that the revertant virus retained only a
single, in-frame copy of the Myc epitope in p12. The cloned PCR
fragment was digested with BsrGI and XhoI and the resulting
640 bp fragment, containing the entire p12 and the Myc epitope
sequence, was used to replace the BsrGI-XhoI wt sequence in
pNCS, to generate the 1xMycR clone. Myc-tagged proteins were
detected by Western blot analysis using mouse monoclonal anti-
Myc antibody (supernatant of 9E10 hybridoma), and a secondary
donkey anti-goat horseradish peroxidase (HRP)-conjugated anti-
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035-147). The PM5 or PM14 mutations in p12 [31] were
introduced by overlapping PCR into the BsrGI-XhoI fragment of
pNCS to generate PM5 or PM14 clones, respectively. Overlap-
ping PCR was also used to combine the Myc epitope of the
1xMycR virus with the PM14 mutation (Fig. 1) in the above
BsrGI-XhoI fragment to generate the 1xMycR/PM14 clone.
pNCAIRES-GFP encodes for a replication-competent MLV, which
expresses the green fluorescent protein (GFP) under the transla-
tional control of the encephalomyocarditis virus internal ribosome
entry site (IRES) [43]. This clone was generously provided by
Jeremy Luban (University of Geneva).
To generate MLV VLPs with Myc-tagged p12 proteins,
containing or lacking the genomic RNA, the following plasmids
and procedure were used: the helper plasmid pVSV.G expresses
the VSV-G glycoprotein. The pGag-PolGpt.p12 1xMycR, is a
derivative of the pGag-PolGpt helper plasmid that expresses the
MLV Gag and Pol proteins, and its p12 sequences was modified to
include the Myc epitope tag as in 1xMycR virus (Fig. 1). The
pQCXIP plasmid encodes an MLV-based vector (Clontech). The
pQCXIPD59 encodes for a defective vector that was generated by
deleting an internal BsrGI fragment from pQCXIP, resulting in
the removal of the 59 LTR and the packaging signal. VLPs were
generated by transfecting subconfluent 293T cells in 60 mm plates
with 10 mg of pQCXIP or pQCXIPD59 together with 7.5 mgo f
pGag-PolGpt.p12 1xMycR and 2.5 mg of pVSV.G DNAs, using
the calcium phosphate procedure. Culture supernatants were
harvested two days posttransfection and used for infection.
Cell cultures
Human embryonic kidney 293T cells, human osteosarcoma
U2OS cells, and the mouse NIH3T3 fibroblasts were cultured in
Dulbecco’s Modified Eagle Medium (DMEM), supplemented with
10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine,
penicillin (20 U/ml), streptomycin (20 mg/ml) and nystatin (2.5 U/
ml), in a humidified incubator at 37v and 5% CO2. All tissue
culture products were purchased from Biological Industries (Beit
Haemek, Israel). To generate human cells stably expressing the
murine receptor for MLV, U2OS cells were transfected with
7.5 mg of pCDNA 3.1 Zeo(+) that encode for the murine receptor
for MLV (mCAT-1; [39]), using the calcium phosphate precip-
itation method. Transfected cells were selected in the presence of
100 mg/ml zeocin for two weeks and zeocin-resistant colonies were
expanded and screened for their susceptibility to MLV infection.
One of the clones (clone #12, named hereafter U/R), was chosen
for further experiments since it could efficiently be infected with
MLV particles encapsidating a MLV vector that expresses the
GFP reporter gene (pQCXIP-gfp-C1 vector [55]; data not shown).
To determine the kinetics of spreading of various MLV clones
in NIH3T3 cultures, the cells were either infected or transfected
with these clones as indicated. The transfection was carried out
using the DEAE-dextran method, as described before [56].
When required, cell synchronization was achieved by arresting
cell division before S phase by serum starvation and aphidicolin
treatment, as previously described [21] and briefly explained here.
On day 1, cells were plated on 13 mm round cover-slips in a 24-
well plate at approximately 5% confluency per well. On day 2,
cells were serum-starved by removing the media, washing the dish
with serum-free media and then adding DMEM containing 0.25%
FCS. On day 4, serum was added to a concentration of 10%. 6 h
after the addition of serum, aphidicolin (2 mg/ml) was added. After
6 h, the medium was removed and fresh medium containing the
virus, 10% serum, polybrene (hexadimethrine bromide; 8 mg/ml)
and aphidicolin (2 mg/ml) was added. After 2 h, the virus-
containing medium was removed and replaced with 10% serum-
containing medium and aphidicolin (2 mg/ml). After an additional
12 h, cells were fixed and subjected to immunofluorescence
analysis.
Immunofluorescence
Cells were grown on 13 mm round cover-slips in a 24-well plate
to ,1.5610
5 cells/well and were infected with the indicated virus
with multiplicity of infection (MOI) of approximately 3 [virus
preparations were estimated to have ,5610
6 infectious units
(IU)/ml, based on comparisons of their RT activity, determined by
RT exogenous assay [57], to a standard MLV stock with known
IU concentration. This stock was made of pNCAIRES-GFP,a
replication-competent MLV that expresses the GFP marker [43],
allowing the determination of its titer by measuring the number of
GFP-positive cells in infected cultures, by fluorescence-activated
cell sorting (FACS) analysis]. Cells were incubated with the virus
for the indicated time, after which they were washed three times
with PBS and fixed with 4% paraformaldehyde for 20 min. After
three washes with 50 mM glycine in PBS, the cells were
permeabilized with 0.1% Triton in PBS for 2 min and
immediately washed three times with PBS. The cells were then
incubated with blocking solution [1:10 normal goat serum in Tris-
Buffered Saline (TBS; 50 mM Tris-HCl, 150 mM NaCl pH 7.5)]
for 30 min, followed by one hour incubation with a mouse
monoclonal anti-Myc antibody (supernatant of 9E10 hybridoma,
diluted 1:6 in TBS), and washed once with TBS and twice with
PBS (5 min each wash). The cells were then incubated for one
hour with a Cy-3-conjugated goat anti-mouse antibody (Jackson
Immunoresearch Laboratories, product no. 115-166-072) diluted
1:500 in TBS and washed once with TBS and twice with PBS
(5 min each wash). The nuclei were stained for 20 min at room
temperature with DAPI (1 mg/ml in PBS), followed by two washes
with PBS. The cover-slips were glued to glass slides with aqueous
mounting media containing anti-fading agent (BIOMEDA). All
the above steps were carried out at room temperature.
For co-localization experiments of p12 and MA or CA proteins,
the immunofluorescence procedure was performed as described
above with the following modifications: the blocking solution was
made of 3% bovine serum albumin (BSA) in PBS and the
supernatant of the 9E10 hybridoma was diluted 1:6 in PBS. Goat
polyclonal anti-MA antiserum (American National Cancer
Institute, product no. 78S-282) or goat polyclonal anti-CA
antiserum (American National Cancer Institute, product
no. 81S-263), were used at a 1:1000 dilution in PBS containing
3% BSA. These antisera were raised against the MA or the CA
proteins of the Rauscher MLV, but cross-react with the MA and
CA proteins of the Moloney MLV, respectively. Secondary
antibodies included the FITC-conjugated F(ab’)2 fragment donkey
anti-mouse IgG (H+L) (Jackson Immunoresearch Laboratories,
product no. 715-096-150), or Red-X- conjugated F(ab’)2 fragment
donkey anti-goat IgG (H+L) (Jackson Immunoresearch Laborato-
ries, product no. 705-296-147), both antibodies were used at a
1:200 dilution in PBS containing 3% BSA.
BX50 microscope (Olympus), LSM 510 META confocal
microscope (Zeiss) or spinning disk confocal (Yokogawa CSU-22
Confocal Head) microscope (Axiovert 200 M, Carl Zeiss
MicroImaging) were used in this study where indicated. Quanti-
fication of the overlap between p12 and chromatin signals was
achieved through the following procedure: Cells, infected with the
1xMycR virus were processed for immunofluorescence analysis as
described above. Then, the entire cell volume was imaged by
confocal microscopy and the picture was deconvolved with the
Nearest Neighbors deconvolution algorithm of SlideBook. Subse-
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dimensional plane. After this, the specific signals of the p12-based
and DAPI-based staining were identified through intensity based
segmentation, the total signal intensity was calculated for each
signal and the percentage of overlapping signal was deduced by
subtraction of the DAPI region of interest (ROI) from the p12
ROI. Approximately 400 dots of p12 signal per image were
analyzed. All the above steps were performed employing the
SlideBook software (Intelligent Imaging Innovations).
Combined immunofluorescence and FISH
Cells were grown on 20620 mm cover-slips in 6-well plates to
30% confluency and were infected with 1 ml media, containing
equal amounts of 1xMycR or wt viruses, normalized by RT
activity using the exogenous RT assay [57]. Unless otherwise
indicated, all the following steps were performed at room
temperature. At the indicated time postinfection, slides were
washed with PBS, fixed with 4% paraformaldehyde in PBS for
10 min, permeabilized with 0.1% Triton in PBS for 10 min,
washed for 10 min in 0.1 M Tris pH 7.4, incubated for 20 min in
20% glycerol in PBS, freeze-thawed three times in liquid nitrogen,
washed once with PBS and once with 0.1% Triton in PBS,
blocked for 30 min with normal goat serum that was diluted 1:10
with PBS, incubated for 60 min with mouse anti-Myc monoclonal
antibody (supernatant of hybridoma 9E10, diluted 1:6 in TBS),
and washed once with TBS for 5 min and twice for 5 min in PBS.
Slides were then incubated for 60 min with a Cy-3-conjugated
goat anti-mouse antibody (Jackson Immunoresearch Laboratories,
product no. 115-166-072, diluted 1:500) and washed once with
TBS and twice with PBS (each wash for 5 min). The slides were
re-fixed in 4% paraformaldehyde in PBS for one min, rinsed with
PBS and incubated in 70% ethanol overnight. To detect the viral
DNA in situ, DNA FISH was performed as described previously
[58] with the following modifications: The following day, the
cover-slips were dried and glued to glass slides with the cells facing
up. The slides were then immersed for 10 min in 0.1M HCl,
10 min in 0.5% Triton X-100 in PBS at 37uC and washed three
times in PBS. Slides were dehydrated by a series of ethanol washes
(70%, 90% and 100%; 5 min each), and incubated at 37uC for
1 hour, followed by denaturation in 70% (v/v) deionized
formamide (F9037, Sigma) in 2xSSC, at 75uC, for 5 min. The
slides were then briefly washed with 70% ethanol and dehydrated
once again in a series of ice-cold ethanol washes (70%, 90% and
100%, 5 min each), air dried and warmed to 37uC. Each slide was
spotted with 10 ml of biotin-labeled probe in hybridization solution
(see below), sealed with glass cover-slips and rubber cement and
incubated in a moist chamber overnight at 37uC. Following
hybridization, the sealing was gently removed and the slides were
washed three times with 50% (v/v) formamide in 2xSSC
(prewarmed to 42uC, 5 min each wash), followed by three washes
with 0.1XSSC (prewarmed to 60uC, 5 min each wash). The slides
were then incubated with blocking solution (3% BSA in 4xSSC,
30–60 min at 37uC). All stages following blocking were carried out
in the dark. The hybridized biotin-labeled probe was detected with
FITC-conjugated avidin (A-2011, Vector Laboratories,1:400
dilution), which was incubated with the slides for 30 min at
37uC in 1% BSA/4xSSC and 0.1% Tween 20. Slides were then
washed three times with 4xSSC and 0.1% Tween 20 (prewarmed
to 42uC, 5 min each wash), and covered with antifade (VECTA-
SHIELD, Vector Laboratories) containing DAPI (200 ng/ml)
under glass cover-slips.
The biotin-labeled probe was prepared in a nick-translation
reaction (100 ml, 2 h at 16uC), containing nick-translation buffer
(50 mM Tris-HCl pH 7.8, 5 mM MgCl2,50 ng/ml BSA), plasmid
DNA template (pNCS, 2 mg), dATP, dGTP, dCTP (50 nM of
each nucleotide, Sigma), and biotin-11-dUTP (50 nM, Roche), b-
mercaptoethanol (10 mM), DNaseI (30 ng/ml, freshly diluted),
Klenow polymerase (20 U, New England Biolabs). A sample (8 ml)
of this reaction was separated in a 2% agarose gel to verify the
generation of a smear, made of approximately 150–500 bp-long
DNA products. The rest of the reaction was kept frozen at 220uC
until used. On the day of the hybridization the probe was ethanol
precipitated with 10 mg of salmon sperm DNA, resuspended in
50 ml of 100% deionized formamide (Sigma, F9037), thoroughly
mixed with 50 ml of 20% dextran sulfate in 2xSSC, denatured
(75uC, 5 min), and immediately applied to the denatured slides
(10 ml/slide).
Co-immunoprecipitation
For Co-IP of the viral genomic DNA, supernatants of sub-
confluent NIH3T3 cultures, chronically infected with the wt or the
1xMycR virus, were harvested, diluted 1:1 with growth medium
and complemented with polybrene (8 mg/ml final concentration).
2 ml of the virus-containing media were used to infect 5610
6
NIH3T3 cells in 10 cm plates for 2 h, after which the media were
replaced with fresh growth media, followed by additional 5 h
incubation. For each IP, 2 plates were trypsinized and the cells
were washed once with PBS. Cell pellets were resuspended in 1 ml
of IP lysis buffer [50 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP-
40, 10 mM MgCl2, 1x protease inhibitor cocktail (Roche, product
no. 1183614500)] and incubated for 30 min at 4uC with constant
agitation. Lysed samples were centrifuged at 20,800 g for 10 min.
5 ml sample of each of the cleared lysates was diluted 1:10, and
triplicates (5 ml each) were analyzed by qPCR. The remaining
lysates were then incubated for 30 minutes at 4uC with 50 mlo f
magnetic polystyrene Dynabeads Protein G (Invitrogen, product
no. 100.03D), pre-conjugated to specific antibodies [the magnetic
beads were pre-incubated with 200 ml of supernatant of the anti-
Myc hybridoma (9E10), or with 0.2 ml (in 200 ml PBS) of anti-Flag
monoclonal antibody (Sigma, F1804), for 10 minutes at room
temperature with a constant agitation and washed once with PBS].
The samples were placed on a magnet and the beads-free lysates
were discarded. The magnetic beads were washed once with IP
washing buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.1% NP-40,
10 mM MgCl2), twice with PBS, and then transferred into a new
tube. The beads were resuspended in 50 ml TE pH 7.4 (10 mM
Tris-Cl pH 7.4, 1 mM EDTA) and 5 ml of the bead slurry were
analyzed by PCR with MLV-specific primers (forward primer
59CCCAGGTTAAGATCAAGG39, and reverse primer 59CTT-
GGCCAAATTGGTGGG39). For qPCR, triplicates (5 ml each) of
the bead slurry were analyzed; real-time PCR reactions were
performed with MLV-specific primers (forward primer 59-
AGCCCTTTGTACACCCTAAGC-39 and reverse primer 59-
GAGGTTCAAGGGGGAGAGAC-39) and Fast SYBR Green
Master Mix (Applied Biosystems, product no. 4385612), and
analyzed with StepOnePlus Real-Time PCR System (Applied
Biosystems). Standard curves were used to determine the absolute
DNA quantity in the samples. To calculate the relative efficiency
of the immunoprecipitation of the viral genomic DNA in the
different experimental settings, the levels of the viral genomic
DNA in the cell extracts and in the IP pellets were quantified by
qPCR, and the background signal obtained in the ‘mock-infected’
sample was subtracted. The level of the immunoprecipitated viral
genomic DNA (IP sample) was divided by the level of this DNA in
the cell lysate (input sample), to give normalized IP value. The
normalized value for the genome of the 1xMycR virus that was
immunoprecipitated with anti-Myc antibodies was set as 100%
and was compared to the normalized values obtained for the
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anti-Flag antibodies, and for the genome of the wt virus that was
immunoprecipitated with anti-Myc antibodies. The average value
of this comparison, obtained from three independent Co-IP
experiments, gave the ‘Relative IP Efficiency’ index.
For Co-IP of CA, infections and lysis of the infected cells were
carried out as described above. To reduce non-specific binding to
the agarose beads that were used for this procedure, the cell lysates
were first incubated for 30 minutes at 4uC with a mixture of 7.5 ml
of protein A-agarose beads (Roche, product no. 11 134 515 001)
and 7.5 ml of protein G-agarose beads (Roche, product no. 11 243
233 001), Then, the lysate-bead slurries were centrifuged at
20,800 g for 2 minutes, the beads were discarded and the cleared
supernatants were incubated overnight at 4uC with 15 ml protein
A and 15 ml G beads, pre-conjugated to specific antibodies [beads
were pre-incubated with 0.5 ml of supernatant of the anti-Myc
hybridoma (9E10) or with 0.5 ml (in 0.5 ml of PBS) of anti-Flag
monoclonal antibody (Sigma, F1804)]. Samples were centrifuged
at 10,000 rpm for 2 min at 4uC and the pelleted beads were
washed once with IP washing buffer, twice with PBS, and directly
boiled in 2x Sample Buffer. The CA protein was detected by
Western blot, using goat anti-MLV CA polyclonal antibody
(National Cancer Institute, product no. 81S-263) and a secondary
donkey anti-goat HRP-conjugated antibody (Jackson Immunor-
esearch Laboratories, product no. 705-035-147). For Co-IP of CA
from extracellular virions, supernatants of sub-confluent NIH3T3
cultures, chronically infected with the wt or the 1xMycR virus,
were harvested and virions were purified from 2 ml of undiluted
medium by ultracentrifugation (107,000 g for 2 h) through 25%
sucrose cushions. Lysis of the virion pellets and CA Co-IP were
performed as described above for the infected cells.
Phylogenetic analysis
The p12 domain of the Gag polyprotein of the Moloney MLV
(SWISS-PROT: P03332) was aligned with 12 homologous
sequences that were retrieved from the SWISS-PROT database,
using a PSI-BLAST search. The sequences were then multiple
aligned (MSA) using the CLUSTALW program, and a phyloge-
netic tree consistent with the MSA was constructed. Calculation of
the conservation scores for each residue was carried out by the
Rate4Site algorithm [59], which is based on the Maximum
Likelihood method. All these stages were curried out automatically
by the ConSeq server (http://conseq.tau.ac.il/), as described in
[60].
Supporting Information
Figure S1 The number of p12 puncta in infected cells correlates
with the amount of virions used for infection. U/R cells were
infected with serial dilutions of the 1xMycR virus and were
processed for immunofluorescence. For each dilution, the number
of p12 puncta in infected cells was visualized using spinning disk
confocal (Yokogawa CSU-22 Confocal Head) microscope (Ax-
iovert 200 M, Carl Zeiss MicroImaging), and the number of
objects (puncta) in the inspected cells was determined employing
the SlideBook software (Intelligent Imaging Innovations). Then,
the average number of p12 puncta per cell, the standard deviation
and the standard error of the mean were calculated (A). The log of
the average number of p12 puncta per cell was plotted against the
log of the dilutions (B). The trend line and its R-squared value
were calculated and drawn using the Microsoft Excel software.
Found at: doi:10.1371/journal.ppat.1001183.s001 (0.15 MB TIF)
Figure S2 Quantification of the overlap between the p12
proteins and the chromosomes. U/R cells were infected with
1xMycR and p12 detection, as well as the staging of the cell cycle
of the infected cells were performed as described in Fig. 4. The
percentages of the p12 signal that overlapped the DAPI signal
were calculated using the SlideBook software (Materials and
Methods) and are presented as columns with standard error bars.
‘n’ denotes the number of individual cells inspected for each stage
of the cell cycle.
Found at: doi:10.1371/journal.ppat.1001183.s002 (0.12 MB TIF)
Figure S3 Detection of the MLV genome in infected cells by
FISH. U/R (A–C) or U20S (D) cells were infected with the wt
virus (A, B and D), or were mock-infected with virus-free medium
(C). 12 h postinfection the cells were processed for FISH analysis,
using MLV-derived, biotin-labeled probe that was detected with a
Cy3-conjugated avidin (ExtrAvidin-Cy3 Conjugate; Sigma,
E4142). The cells were visualized with a BX50 microscope
(Olympus). Bars represent 10 mm.
Found at: doi:10.1371/journal.ppat.1001183.s003 (2.16 MB TIF)
Figure S4 Detection of viral p12 proteins and genomic DNA by
immunofluorescence combined with FISH. U/R cells were
infected and processed for immunofluorescence combined with
FISH, as described in Fig. 6. The entire cell volume was imaged
with a LSM 510 META confocal microscope (Zeiss). Micrograph
depicts a middle Z section (the 6th of 11 sections) of the nucleus of
a dividing cell. This section is visualized in the x,y plane (large
square), x,z plane (upper rectangle) and y,z plane (side rectangle).
Arrows point to doubly-labeled puncta (green and red yielding a
yellow signal) that localize to the center of the condensed
chromatin (blue). The image was created with the LSM Image
Browser software (Zeiss).
Found at: doi:10.1371/journal.ppat.1001183.s004 (2.99 MB TIF)
Figure S5 Quantification of the fluorescent puncta in immuno-
fluorescence combined with FISH analysis. U/R cells were
infected with 1xMycR virus and processed at the indicated time
postinfection for immunofluorescence combined with FISH
analysis, as described in Fig. 6. Microscopic images of the cells
were inspected manually for fluorescent puncta, to determine the
p12 (red), viral DNA (green) and the overlap (yellow) fluorescence
of each dot (upper table). Numbers in brackets represent the
number of fluorescent dots that overlapped the DAPI staining of
the chromosomes. The numbers of the dots with the red, green or
yellow fluorescence are presented as percentages of the total
number of the fluorescent dots, at each time point postinfection,
(columns chart). Quantification of the fluorescence of the
extracellular puncta is presented at the lower table.
Found at: doi:10.1371/journal.ppat.1001183.s005 (0.23 MB TIF)
Figure S6 Generation of p12 puncta in infected cells is
independent of the presence of the genomic RNA in infecting
particles. 293T cells were transfected with a mixture of the helper
plasmids pGag-PolGpt.p12 1xMycR and pVSV.G; this mixture
also included either the pQCXIP plasmid encoding an MLV-
based vector, or its derivative - the pQCXIPD59 plasmid that
contains a defective vector, lacking both the 59 LTR and the
packaging signal. This defective vector was used to generate VLPs
with no packaged genomic RNA. Two days posttransfection,
equal amounts of virions in the culture supernatants (normalized
by an exogenous RT assay) were used to infect U/R cells. p12 was
visualized by immunofluorescence as described in Fig. 3. Shown
are representative images of interphasic (A, B, D and E) and
mitotic (C and E) cells, infected with VLPs containing (A-C) or
lacking (D–F) the genomic RNA. Bars represent 10 mm.
Found at: doi:10.1371/journal.ppat.1001183.s006 (3.00 MB
TIF)
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proteins. (A) qPCR analysis of the level of the genomic DNA of the
indicated viruses in the lysates of infected cells (‘Input’), and in
samples of the magnetic beads (‘IP’) that were coupled to the
indicated antibodies. Each value represents the average of three
triplicates of the tested sample. For Co-IP of CA, supernatants of
NIH3T3 cultures, chronically infected with the indicated virus,
were harvested and 2 ml were used to infect naı ¨ve NIH3T3 cells.
Virions from additional 2 ml culture supernatants were purified by
ultracentrifugation through 25% sucrose cushions. Lysates were
prepared both from the extracellular virions and from the infected
cells and were subject to IP as described in Fig. 7C. 5% of the
virion or cell lysate samples and 100% of the IP samples were
examined by Western blot analysis, to detect CA in lysates and IP
pellets of virions (B) and infected cells (C). ‘1xMycR*’ indicates the
samples of 1xMycR-infected cells and 1xMycR virions, used for IP
reactions with anti-Flag antibodies.
Found at: doi:10.1371/journal.ppat.1001183.s007 (0.78 MB TIF)
Figure S8 Quantification of the overlap between p12 and the
chromosomes in 1xMycR or 1xMycR/PM14 -infected cells. U/R
cells were infected with 1xMycR or 1xMycR/PM14 viruses and
p12 detection, as well as the staging of the cell cycle of the infected
cells were performed as described in Fig. 4. The percentages of the
p12 signal that overlapped the DAPI signal were calculated using
the SlideBook software as described in Fig. S2 and are presented as
columns with standard error bars. For the analysis of p12 puncta
derived from the 1xMycR/PM14 virus, 2 and 10 interphasic and
mitotic cells were inspected, respectively; the results of this analysis
were compared to the ones obtained for the 1xMycR virus in Fig.
S2. For both infections, ‘mitosis’ refers to the average overlap that
was calculated for dividing cells regardless of their specific stage in
mitosis. Student’s t-test analyses show highly significant differences
in the overlap of p12 with chromosomes between mitotic and
interphasic cells for the 1xMycR virus (p,10
215); similarly highly
significant differences in the overlap were observed amongst the
1xMycR or 1xMycR/PM14 viruses in mitotic cells (p,10
217);
and an absence of such differences for either the two viruses in
interphasic cells or for the 1xMycR/PM14 in mitotic and
interphasic cells (p.0.4).
Found at: doi:10.1371/journal.ppat.1001183.s008 (0.10 MB TIF)
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